Capstone Investment Advisors
AVNS

Capstone Investment Advisors’s Avanos Medical AVNS Stock Holding History

Capstone Investment Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,280
Closed -$382K – 353
2017
Q4 		$382K Buy
8,280
+2,837
+52% +$130K 0.01% 319
2017
Q3 		$245K Buy
+5,443
New +$232K 0.01% 432
2017
Q2 		– Sell
-13,760
Closed -$524K – 634
2017
Q1 		$524K Buy
13,760
+1,110
+9% +$43.3K 0.01% 587
2016
Q4 		$467K Sell
12,650
-653
-5% -$23.3K 0.01% 597
2016
Q3 		$461K Buy
+13,303
New +$466K 0.01% 531

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capstone Investment Advisors's AVNS Position: Q1 2018 in Review

Capstone Investment Advisors sold out of Avanos Medical (AVNS) in Q1 2018, closing a stake of 8,280 shares — an estimated $382K sold.

Capstone Investment Advisors first reported a position in AVNS in Q3 2016 and held it in 5 quarters. The position peaked at $524K in Q1 2017. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2018.

  • Capstone Investment Advisors reported no remaining Avanos Medical position as of Q1 2018 after selling out during the quarter.
  • Capstone Investment Advisors sold 8,280 Avanos Medical shares in Q1 2018, an estimated $382K.
  • Capstone Investment Advisors first reported a position in Avanos Medical in Q3 2016 and held it in 5 quarters.
  • Capstone Investment Advisors's Avanos Medical position peaked at $524K in Q1 2017.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2018.

Based on Capstone Investment Advisors's 13F filing for Q1 2018, filed 15 May 2018.